Therapeutic Processes and Treatment Outcome in Adolescents With Anxiety Disorders

This study has been completed.
Sponsor:
Collaborator:
Information provided by:
Temple University
ClinicalTrials.gov Identifier:
NCT00071630
First received: October 29, 2003
Last updated: November 6, 2013
Last verified: September 2008
  Purpose

The purpose of this study is to examine the relationship between different aspects of cognitive behavior therapy (CBT) and treatment outcome.


Condition Intervention Phase
Anxiety Disorders
Behavioral: Cognitive Behavioral Therapy
Phase 4

Study Type: Interventional
Study Design: Allocation: Non-Randomized
Endpoint Classification: Efficacy Study
Intervention Model: Single Group Assignment
Masking: Open Label
Primary Purpose: Treatment
Official Title: Process as a Predictor of Outcomes in CBT for Youth

Resource links provided by NLM:


Further study details as provided by Temple University:

Estimated Enrollment: 130
Study Start Date: September 2002
Estimated Study Completion Date: August 2005
Detailed Description:

Anxiety disorders are common among children; if untreated, they can negatively affect children's lives. Evidence suggests that CBT can benefit children with anxiety disorders, but the causal mechanisms between therapy and beneficial outcomes have not been thoroughly investigated.

Audio and videotaped sessions of children currently receiving CBT and those who received CBT in previous trials will be examined. Various rating scales will be used to rate therapeutic alliance, child involvement, and therapist flexibility for each session of CBT. To evaluate potential process variables that contribute to participant drop-out, this study will compare the early process variables for children who complete treatment and for those who discontinue treatment.

  Eligibility

Ages Eligible for Study:   8 Years to 13 Years
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No
Criteria

Inclusion criteria:

  • Diagnosis of separation anxiety disorder, generalized anxiety disorder, or social phobia
  • At least one English-speaking parent

Exclusion criteria:

  • IQ < 80
  • Psychotic symptoms
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its ClinicalTrials.gov identifier: NCT00071630

Locations
United States, Pennsylvania
Temple University
Philadelphia, Pennsylvania, United States, 19122
Australia, New South Wales
Macquarie University
Sydney, New South Wales, Australia, 2109
Sponsors and Collaborators
Temple University
  More Information

Additional Information:
No publications provided

ClinicalTrials.gov Identifier: NCT00071630     History of Changes
Other Study ID Numbers: R01 MH64484, R01MH064484, DSIR CT-S
Study First Received: October 29, 2003
Last Updated: November 6, 2013
Health Authority: United States: Federal Government

Keywords provided by Temple University:
Adolescent

Additional relevant MeSH terms:
Anxiety Disorders
Disease
Mental Disorders
Pathologic Processes

ClinicalTrials.gov processed this record on October 30, 2014